S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
SHOCKING Crypto Leak… (Ad)
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
The “Perfect Storm” for Gold (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
Biden replacement revealed? (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
NASDAQ:ZSAN

Zosano Pharma (ZSAN) Stock Price, News & Analysis

→ Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad)
Free ZSAN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$0.0002
▼
$0.0002
50-Day Range
$0.52
▼
$112.00
52-Week Range
$0.46
▼
$37.45
Volume
5,685 shs
Average Volume
425,375 shs
Market Capitalization
$980.40
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
ZSAN stock logo

About Zosano Pharma Stock (NASDAQ:ZSAN)

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California.

ZSAN Stock News Headlines

April 12, 2024 | seekingalpha.com
HOOK HOOKIPA Pharma Inc.
May 18, 2023 | bizjournals.com
East Bay Business News
April 18, 2024 | TradeSmith (Ad)
A.I. Pioneer Issues Urgent Warning to Americans
With artificial intelligence creeping into every facet of our lives, what should you be doing to "A.I.-Proof" your future? It's the question on many of our minds.
April 6, 2023 | forbes.com
Astellas Pharma
February 5, 2023 | finance.yahoo.com
Giiant Pharma Receives Financial Support From the US Crohn’s and Colitis Foundation
November 5, 2022 | ca.finance.yahoo.com
Zosano Pharma Corporation (ZSANQ)
October 12, 2022 | msn.com
Bankrupt Zosano Sells Its Drug Delivery Tech That Once Partnered With Pharma Giants
August 28, 2022 | marketwatch.com
Bankrupt Zosano Pharma Says Unsecured Creditors Will Recoup 28% of Claims
April 18, 2024 | Paradigm Press (Ad)
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
August 27, 2022 | bizjournals.com
East Bay migraine patch developer Zosano closes sale in bankruptcy court for $1 million
August 25, 2022 | investing.com
Zosano Pharma Corp (ZSANQ)
July 26, 2022 | bizjournals.com
East Bay company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M
July 26, 2022 | bizjournals.com
A Fremont company promised drug-coated microneedle patches. Now it could be sold in bankruptcy court for just $1M.
June 2, 2022 | marketwatch.com
Zosano Pharma Shares Slide to New Depths After Chapter 11 Filing >ZSAN
June 2, 2022 | msn.com
Why Zosano Pharma Shares Are Getting Hammered Today
June 2, 2022 | seekingalpha.com
Zosano Pharma files for Chapter 11 bankruptcy protection; shares plummet 46%
June 2, 2022 | marketwatch.com
Cash-Strapped Zosano Pharma Files for Chapter 11 Bankruptcy >ZSAN
June 2, 2022 | bizjournals.com
East Bay migraine patch developer files for bankruptcy
June 2, 2022 | finance.yahoo.com
Zosano Pharma Files Voluntary Petition for Relief Under Chapter 11
May 18, 2022 | apnews.com
Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive COVID-19 Vaccine onto Zosano Pharma’s Micro-Needle Patch
May 13, 2022 | investing.com
Zosano Pharma Reports Q1 Net Loss of $33.4M
May 13, 2022 | finance.yahoo.com
Zosano Pharma Reports First Quarter 2022 Financial Results
May 3, 2022 | finance.yahoo.com
Zosano Pharma Corporation (ZSAN) Outpaces Stock Market Gains: What You Should Know
April 29, 2022 | bizjournals.com
Migraine patch Zosano Pharma developer suspends program, cutting more jobs
April 29, 2022 | finance.yahoo.com
Migraine patch developer Zosano Pharma suspends program, cutting more jobs
April 29, 2022 | seekingalpha.com
Zosano Pharma suspends program for migraine treatment M207
April 29, 2022 | finance.yahoo.com
Zosano Pharma Provides Corporate Update
See More Headlines
Receive ZSAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zosano Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2022
Today
4/18/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ZSAN
CUSIP
N/A
CIK
1587221
Web
www.zosanopharma.com
Phone
(510) 745-1200
Fax
N/A
Employees
40
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($14.5034)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-29,920,000.00
Net Margins
-8,375.11%
Pretax Margin
-8,375.11%
Return on Equity
-177.06%
Return on Assets
-119.14%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.61
Quick Ratio
1.61

Sales & Book Value

Annual Sales
$790,000.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$9.74 per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
4,902,000
Free Float
4,784,000
Market Cap
$980.40
Optionable
Not Optionable
Beta
3.30
The Best High-Yield Dividend Stocks for 2024 Cover
The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

ZSAN Stock Analysis - Frequently Asked Questions

How were Zosano Pharma's earnings last quarter?

Zosano Pharma Co. (NASDAQ:ZSAN) released its quarterly earnings results on Friday, May, 13th. The biotechnology company reported ($1.76) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($1.75) by $0.01. Zosano Pharma had a negative trailing twelve-month return on equity of 177.06% and a negative net margin of 8,375.11%.

When did Zosano Pharma's stock split?

Shares of Zosano Pharma reverse split on the morning of Tuesday, April 12th 2022. The 1-35 reverse split was announced on Tuesday, April 12th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, April 12th 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Zosano Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Zosano Pharma investors own include Aeterna Zentaris (AEZS), Pennsylvania Real Estate Investment Trust (PEI), Bionano Genomics (BNGO), Gran Tierra Energy (GTE), CNBX Pharmaceuticals (CNBX), Matinas BioPharma (MTNB), ADMA Biologics (ADMA), Novan (NOVN), Hallador Energy (HNRG) and EnLink Midstream (ENLC).

When did Zosano Pharma IPO?

Zosano Pharma (ZSAN) raised $47 million in an IPO on Tuesday, January 27th 2015. The company issued 4,300,000 shares at a price of $10.00-$12.00 per share. Ladenburg Thalmann and Roth Capital Partners served as the underwriters for the IPO.

This page (NASDAQ:ZSAN) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
SHOCKING Crypto Leak…
Crypto 101 Media
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
The #1 Crypto for 2024
InvestorPlace
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company
Options trading has suddenly become more reliable.
Eagle Publishing